Verified employee & interview reviews

Metropolis Healthcare Reviews

Mumbai, Maharashtra

—/ 5

0 reviews

Metropolis Healthcare Limited is a leading and prominent multinational diagnostics company in India, operating as the second-largest player in the country's diagnostic industry. Established in 1980 by Dr. Sushil Kanubhai Shah, the company began as a single diagnostic laboratory in Mumbai, Maharashtra. Over more than four decades, Metropolis has expanded into a comprehensive healthcare network with a robust presence across urban and semi-urban markets, primarily focusing on high-end specialized testing and a direct-to-consumer (B2C) model. The company operates an extensive hub-and-spoke operational network that spans 28 states, seven Union Territories, and over 750 towns across India. This domestic infrastructure is supported by a network of over 220 clinical laboratories, 4,450 service centers, and more than 10,000 digital and physical touchpoints. Beyond its extensive footprint in India, Metropolis has established a strong international presence, making it the largest diagnostics provider in Africa, with operations in five countries on the continent and a total international business-to-business (B2B) presence across 12 countries, including Sri Lanka, Ghana, Kenya, Zambia, Uganda, and Mauritius. Metropolis offers a comprehensive test menu comprising over 4,000 clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its core services focus on pathology, covering branches such as biochemistry, hematology, histopathology, and microbiology. Its advanced diagnostic portfolio includes highly specialized genetic, molecular, and cytogenetic testing, alongside customized wellness profiles, preventive healthcare screening packages, clinical trial research, and hospital lab management services. The company is promoter-led under the leadership of Founder and Chairman Emeritus Dr. Sushil Shah, Executive Chairperson Ms. Ameera Shah, and CEO Mr. Surendran Chemmenkotil. Its medical and technical team consists of over 2,000 members, guided by a specialized panel of 200 senior pathologists and doctors. Strategically, Metropolis continues to pursue inorganic growth through active acquisitions, recently integrating regional entities like Core Diagnostics, DAPIC, Scientific Pathology, and Ambika Pathology to expand its market penetration. Financially, Metropolis Healthcare Limited is a publicly traded entity listed on both the National Stock Exchange (NSE: METROPOLIS) and the Bombay Stock Exchange (BSE: 542650). Headquartered in Worli, Mumbai, the company reported consolidated revenue from operations of INR 1,331.20 crore, an adjusted EBITDA of INR 325 crore, and an adjusted profit after tax (PAT) of INR 161 crore for the fiscal year 2025. The brand maintains a high Net Promoter Score (NPS) of 87, reflecting strong customer loyalty across its massive annual base of over 12.67 million serviced patients.